Botanix Pharmaceuticals Limited PEG Ratio

Botanix Pharmaceuticals Limited (BXPHF) currently reports a PEG ratio of 0.91. That is below the Healthcare sector average of 12.15. Use the charts on this page to explore Botanix Pharmaceuticals Limited's PEG ratio history and peer comparisons.

Botanix Pharmaceuticals Limited's PEG ratio of 0.91 is lower than the Healthcare sector average of 12.15. That is roughly 92.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Botanix Pharmaceuticals Limited's market price to a fundamental measure such as earnings, sales, or book value. At 0.91, BXPHF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 0.91, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 12.15. From there, open related valuation or income-statement pages for Botanix Pharmaceuticals Limited, and consider following BXPHF for alerts when major investors trade the stock.

Botanix Pharmaceuticals Limited is classified in the Healthcare sector. On PEG ratio, it currently shows 0.91 versus a sector average near 12.15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BXPHF with unrelated industries.